Published in J Clin Invest on August 01, 1995
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev (1996) 3.46
Complete genome sequence of Vibrio fischeri: a symbiotic bacterium with pathogenic congeners. Proc Natl Acad Sci U S A (2005) 3.05
Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol (2009) 2.63
Comparative genomics of the FtsK-HerA superfamily of pumping ATPases: implications for the origins of chromosome segregation, cell division and viral capsid packaging. Nucleic Acids Res (2004) 2.62
In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J (2000) 2.32
Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut (2008) 2.30
The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol (2011) 2.12
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut (2003) 1.84
Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli. Infect Immun (1999) 1.65
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39
Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cells. Infect Immun (2000) 1.36
Activation of host cell protein kinase C by enteropathogenic Escherichia coli. Infect Immun (1997) 1.32
Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest (1997) 1.31
Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells. Infect Immun (1996) 1.30
Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun (1997) 1.26
NSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cells. J Virol (2001) 1.22
Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro. Gut (1999) 1.18
Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol (1996) 1.13
Vibrio parahaemolyticus thermostable direct hemolysin modulates cytoskeletal organization and calcium homeostasis in intestinal cultured cells. Infect Immun (1999) 1.03
The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One (2013) 1.00
Localization of dysfunctional tight junctions in Salmonella enterica serovar typhimurium-infected epithelial layers. Infect Immun (2000) 0.99
Genomic investigation into strain heterogeneity and pathogenic potential of the emerging gastrointestinal pathogen Campylobacter ureolyticus. PLoS One (2013) 0.99
Basics and recent advances in peptide and protein drug delivery. Ther Deliv (2013) 0.98
Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb) (2013) 0.98
Intestinal zonulin: open sesame! Gut (2001) 0.97
Inflammation-associated repression of vasodilator-stimulated phosphoprotein (VASP) reduces alveolar-capillary barrier function during acute lung injury. FASEB J (2009) 0.96
Absorption enhancers for nasal drug delivery. Clin Pharmacokinet (2003) 0.95
Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med (2008) 0.95
Mechanisms of disease: protease functions in intestinal mucosal pathobiology. Nat Clin Pract Gastroenterol Hepatol (2007) 0.94
Comparative analyses of Campylobacter concisus strains reveal the genome of the reference strain BAA-1457 is not representative of the species. Gut Pathog (2011) 0.93
The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers (2013) 0.91
Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol (2008) 0.89
Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens. Infect Immun (1999) 0.89
Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses. Infect Immun (2003) 0.86
The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases. Am J Pathol (2009) 0.86
Vibrio cholerae-induced inflammation in the neonatal mouse cholera model. Infect Immun (2014) 0.85
Novel cholix toxin variants, ADP-ribosylating toxins in Vibrio cholerae non-O1/non-O139 strains, and their pathogenicity. Infect Immun (2012) 0.85
Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers. J Membr Biol (2005) 0.82
In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines. Front Immunol (2013) 0.81
Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model. PLoS One (2016) 0.81
Case studies in cholera: lessons in medical history and science. Yale J Biol Med (2001) 0.81
Epithelial barrier modulation by a channel forming peptide. J Membr Biol (2008) 0.80
Toxins and the gut: role in human disease. Gut (2002) 0.80
Human isolates of Cronobacter sakazakii bind efficiently to intestinal epithelial cells in vitro to induce monolayer permeability and apoptosis. J Surg Res (2011) 0.80
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers (2016) 0.78
Draft Genome Sequence of Campylobacter corcagiensis Strain CIT045T, a Representative of a Novel Campylobacter Species Isolated from Lion-Tailed Macaques (Macaca silenus). Genome Announc (2014) 0.78
Genome Sequence of the Urethral Catheter Isolate Pseudomonas aeruginosa MH19. Genome Announc (2015) 0.78
Cloning of genes of nontypeable Haemophilus influenzae involved in penetration between human lung epithelial cells. Infect Immun (2000) 0.78
Campylobacter ureolyticus: a portrait of the pathogen. Virulence (2014) 0.78
Retracted Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin. J Drug Target (2006) 0.77
Zonula occludin toxin, a microtubule binding protein. World J Gastroenterol (2000) 0.77
Comparative analysis of theophylline and cholera toxin in rat colon reveals an induction of sealing tight junction proteins. Pflugers Arch (2014) 0.77
Distribution of Putative Virulence Genes and Antimicrobial Drug Resistance in Vibrio harveyi. Indian J Microbiol (2011) 0.76
Genome-Wide Analysis of Oceanimonas sp. GK1 Isolated from Gavkhouni Wetland (Iran) Demonstrates Presence of Genes for Virulence and Pathogenicity. Cell J (2015) 0.75
Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery. Drug Des Devel Ther (2015) 0.75
Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci (2017) 0.75
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells. Sci Rep (2016) 0.75
Vibrio cholerae hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activities. Toxicon (2016) 0.75
Regulation of intestinal permeability: The role of proteases. World J Gastroenterol (2017) 0.75
Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers (2016) 0.75
MPA Modulates Tight Junctions' Permeability via Midkine/PI3K Pathway in Caco-2 Cells: A Possible Mechanism of Leak-Flux Diarrhea in Organ Transplanted Patients. Front Physiol (2017) 0.75
Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol (1993) 10.65
Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature (1992) 5.72
Structure, biochemistry, and assembly of epithelial tight junctions. Am J Physiol (1987) 4.58
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Structure, function, and regulation of cellular tight junctions. Am J Physiol (1992) 4.20
Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc Natl Acad Sci U S A (1991) 3.60
MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature (1992) 3.49
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A (1991) 3.43
Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J Membr Biol (1987) 3.40
Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest (1988) 3.12
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature (1984) 3.08
Twenty-first Bowditch lecture. The epithelial junction: bridge, gate, and fence. Physiologist (1977) 2.90
Submembranous junctional plaque proteins include potential tumor suppressor molecules. J Cell Biol (1993) 2.87
A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet (1983) 2.62
Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature (1991) 2.60
Intestinal absorptive cell tight junctions are linked to cytoskeleton. Am J Physiol (1987) 2.58
Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol (1986) 2.53
The origin and characteristics of a pig kidney cell strain, LLC-PK. In Vitro (1976) 2.44
Immune complexes containing food proteins in normal and atopic subjects after oral challenge and effect of sodium cromoglycate on antigen absorption. Lancet (1979) 2.23
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect Immun (1992) 2.18
Retracted A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int J Cancer (1989) 1.93
Loosening tight junctions. Lessons from the intestine. J Clin Invest (1989) 1.92
The structure and regulation of tight junctions. Curr Opin Cell Biol (1993) 1.89
Crohn's disease--a permeability disorder of the tight junction? Gut (1988) 1.82
Expression, purification, and characterization of protein kinase C-epsilon. J Biol Chem (1990) 1.61
Establishment and characterizaton of intestinal epithelial cell cultures. Methods Cell Biol (1980) 1.59
Activation of protein kinase C results in the displacement of its myristoylated, alanine-rich substrate from punctate structures in macrophage filopodia. J Exp Med (1990) 1.55
Clostridium difficile toxin A and its effects on cells. Toxicon (1991) 1.54
Signal transduction and the actin cytoskeleton: the roles of MARCKS and profilin. Trends Biochem Sci (1992) 1.51
The effect of neutrophil migration on epithelial permeability. J Cell Biol (1986) 1.48
The protein kinase C family. Eur J Biochem (1992) 1.39
Ca2+ regulation of tight-junction permeability and structure in Necturus gallbladder. Am J Physiol (1983) 1.39
Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression. Cell Growth Differ (1994) 1.37
C. difficile toxin A increases intestinal permeability and induces Cl- secretion. Am J Physiol (1990) 1.37
CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect Immun (1993) 1.35
The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration. Lab Invest (1988) 1.32
The surface epithelium of teleostean fish gills. Cellular and junctional adaptations of the chloride cell in relation to salt adaptation. J Cell Biol (1979) 1.29
Alteration of tight junctional permeability in the rat parotid gland after isoproterenol stimulation. J Cell Biol (1984) 1.26
Clostridium difficile toxin B induces reorganization of actin, vinculin, and talin in cultured cells. Exp Cell Res (1988) 1.19
The role of phosphorylation in development of tight junctions in cultured renal epithelial (MDCK) cells. Biochem Biophys Res Commun (1991) 1.10
Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J Cell Physiol (1993) 1.08
Development of intercellular junctions in the pulmonary epithelium of the foetal lamb. J Cell Sci (1978) 1.07
Expression and partial characterization of rat protein kinase C-delta and protein kinase C-zeta in insect cells using recombinant baculovirus. J Cell Biochem (1992) 1.06
Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J Clin Microbiol (1993) 1.02
Oxidants and conductance of cultured epithelial cell monolayers: inositol phospholipid hydrolysis. Am J Physiol (1988) 1.01
Reversible disassembly of an intestinal epithelial monolayer by prolonged exposure to phorbol ester. Am J Physiol (1994) 0.99
cAMP-mediated effects of ouabain and theophylline on paracellular ion selectivity. Am J Physiol (1984) 0.98
Dual role for protein kinase C alpha as a regulator of ion secretion in the HT29cl.19A human colonic cell line. Biochem J (1992) 0.95
The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp Cell Res (1993) 0.95
Regulation of paracellular permeability in Caco-2 cell monolayers by protein kinase C. Am J Physiol (1993) 0.93
Control of actin filament length by phosphorylation of fragmin-actin complex. J Cell Biol (1990) 0.92
Cellular variability in the development of tight junctions after activation of protein kinase C. Am J Physiol (1992) 0.87
Relationship between intercellular permeability and junction organization in the preimplantation mouse embryo. Dev Biol (1978) 0.81
Studies on proteolysis of protein kinase C with calpain I and II. Kobe J Med Sci (1990) 0.80
TPA causes divergent responses of Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC in the nuclei of Caco-2 cells. Biochim Biophys Acta (1994) 0.79
Identification of protein kinase C-alpha, epsilon and zeta in rabbit ileal enterocytes. Comp Biochem Physiol Pharmacol Toxicol Endocrinol (1994) 0.78
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun (1991) 15.39
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A (1990) 14.22
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A (1995) 12.79
Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol (2000) 9.51
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis (1985) 9.18
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis (1987) 8.19
Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J Infect Dis (1985) 7.78
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev (1983) 7.16
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J (1987) 7.15
Plasmid-mediated adhesion in enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr (1983) 6.59
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A (1995) 6.59
The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol (1998) 6.38
Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J Clin Microbiol (1982) 6.34
Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol (1998) 6.12
Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol (1992) 6.09
The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid. Infect Immun (1991) 5.75
Enteropathogenic Escherichia coli. Infect Immun (1992) 5.74
A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol Microbiol (1997) 5.55
Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli. Infect Immun (1985) 5.42
Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis (1988) 5.30
A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J Bacteriol (1993) 5.02
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci U S A (1998) 4.75
Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells. Infect Immun (1990) 4.72
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest (1993) 4.53
Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis (1989) 4.52
Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells. Infect Immun (1987) 4.48
Molecular characterization of environmental and nontoxigenic strains of Vibrio cholerae. Infect Immun (1981) 4.45
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen. J Infect Dis (1990) 4.43
Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli. Proc Natl Acad Sci U S A (1999) 4.42
Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med (1979) 4.36
Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect Immun (1998) 4.33
Vibrio parahaemolyticus and related halophilic Vibrios. Crit Rev Microbiol (1982) 4.24
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet (1988) 4.12
The Per regulon of enteropathogenic Escherichia coli : identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol (1999) 4.12
The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest (1993) 4.11
A plasmid-encoded type IV fimbrial gene of enteropathogenic Escherichia coli associated with localized adherence. Mol Microbiol (1992) 3.93
A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature (1999) 3.89
Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells. Infect Immun (1992) 3.82
A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli. Infect Immun (1995) 3.77
Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol Rev (1996) 3.46
Quorum sensing is a global regulatory mechanism in enterohemorrhagic Escherichia coli O157:H7. J Bacteriol (2001) 3.43
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A (1991) 3.43
Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun (1994) 3.36
Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature (1997) 3.31
The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun (2000) 3.20
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis (1988) 3.19
Plasmid and chromosomal elements involved in the pathogenesis of attaching and effacing Escherichia coli. Infect Immun (1991) 3.13
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature (1984) 3.08
Detection of the thermostable direct hemolysin gene and related DNA sequences in Vibrio parahaemolyticus and other vibrio species by the DNA colony hybridization test. Infect Immun (1985) 2.90
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82
Thermostable direct hemolysin gene of Vibrio parahaemolyticus: a virulence gene acquired by a marine bacterium. Infect Immun (1995) 2.81
Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A (1993) 2.81
Interactions between enteropathogenic Escherichia coli and host epithelial cells. Trends Microbiol (1997) 2.73
The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect Immun (1995) 2.69
Nucleotide sequence of the thermostable direct hemolysin gene of Vibrio parahaemolyticus. J Bacteriol (1985) 2.66
Variable assortment of prophages provides a transferable repertoire of pathogenic determinants in Salmonella. Mol Microbiol (2001) 2.63
Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. J Infect Dis (1992) 2.62
Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA (1993) 2.59
Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med (1975) 2.57
Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro. J Infect Dis (1991) 2.53
Localization of a determinant for HEp-2 adherence by enteropathogenic Escherichia coli. Infect Immun (1986) 2.52
Diffuse-adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico. J Infect Dis (1991) 2.52
Distribution of the bundle-forming pilus structural gene (bfpA) among enteropathogenic Escherichia coli. J Infect Dis (1993) 2.50
Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect Immun (1996) 2.47
Cloning of the cytotoxin-hemolysin gene of Vibrio vulnificus. Infect Immun (1985) 2.42
Aeromonas hydrophila: ecology and toxigenicity of isolates from an estuary. J Appl Bacteriol (1981) 2.42
Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro. Infect Immun (1998) 2.41
Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J Clin Invest (1995) 2.41
Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol (1985) (1985) 2.40
The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest (1996) 2.39
Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun (1992) 2.35
Morphological studies on fimbriae expressed by Vibrio cholerae 01. Microb Pathog (1988) 2.33
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci U S A (1993) 2.28
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Nucleotide sequence analysis of the A2 and B subunits of Vibrio cholerae enterotoxin. J Biol Chem (1983) 2.20
The Vibrio cholerae genome contains two unique circular chromosomes. Proc Natl Acad Sci U S A (1998) 2.18
Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect Immun (1992) 2.18
Heterogeneous virulence of enteroaggregative Escherichia coli strains isolated from children in Southwest Nigeria. J Infect Dis (2000) 2.12
EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun (2001) 2.12
Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation (1979) 2.11
Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc Natl Acad Sci U S A (1994) 2.11
An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. J Infect Dis (1997) 2.10
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis (1995) 2.10
Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli. Proc Natl Acad Sci U S A (1984) 2.10
Duplication and variation of the thermostable direct haemolysin (tdh) gene in Vibrio parahaemolyticus. Mol Microbiol (1990) 2.07
An activator of glutamate decarboxylase genes regulates the expression of enteropathogenic Escherichia coli virulence genes through control of the plasmid-encoded regulator, Per. Mol Microbiol (2001) 2.07
Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections. J Clin Microbiol (1987) 2.07
Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. J Clin Invest (1996) 2.07
Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill (2007) 2.07
Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther (1977) 2.03
Indole can act as an extracellular signal in Escherichia coli. J Bacteriol (2001) 2.03
espC pathogenicity island of enteropathogenic Escherichia coli encodes an enterotoxin. Infect Immun (2001) 2.03
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol Microbiol (1999) 2.00